StimCell Energetics Inc. (STME)

OTCMKTS · Delayed Price · Currency is USD
0.3489
+0.0289 (9.03%)
May 28, 2026, 9:30 AM EST
Market Cap7.38M +3.4%
Revenue (ttm)n/a
Net Income-885.25K
EPS-0.04
Shares Out 21.14M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,000
Open0.3489
Previous Close0.3200
Day's Range0.3489 - 0.3489
52-Week Range0.2500 - 0.4800
Beta46.38
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About StimCell Energetics

StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for thr... [Read more]

Sector Healthcare
Founded 2010
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol STME
Full Company Profile

Financial Performance

Financial Statements

News

Stonegate Initiates Coverage on StimCell Energetics Inc. (STME)

Dallas, Texas--(Newsfile Corp. - May 15, 2026) - StimCell Energetics Inc. (OTCQB: STME): Stonegate Initiates Coverage on StimCell Energetics Inc. (OTCQB: STME). StimCell is a single-product company fo...

14 days ago - Newsfile Corp

StimCell Energetics Engages Stonegate Capital Partners for Research Coverage and Institutional Investor Outreach

VANCOUVER, BC / ACCESS Newswire / March 19, 2026 / StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, and...

2 months ago - Accesswire

StimCell Energetics Inc. Announces Study into eBalance(R) Device's Impact on Neuronal Mitochondrial Function

VANCOUVER, BC / ACCESS Newswire / December 2, 2025 / StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, a...

6 months ago - Accesswire

StimCell Energetics Inc. Successfully Uplists to OTCQB Market

VANCOUVER, BC / ACCESS Newswire / October 24, 2025 / StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, a...

7 months ago - Accesswire

StimCell Energetics Provides Sneak Peek at eBalance Redesign Progress and Announces Shares for Debt Transaction and the Engagement of Independent Investor Relations Consultant

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / March 26, 2025 / StimCell Energetics Inc. (OTC PINK:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness...

1 year ago - Accesswire

StimCell Energetics Partners With ADM Tronics to Redesign eBalance Microcurrent Device for Home Use

Innovative Redesign Brings Smaller, Cost-Effective Unit with Advanced Diagnostics to Consumers VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / February 25, 2025 / StimCell Energetics Inc. (OTC PINK:ST...

1 year ago - Accesswire